UNIVERSITY OF SYDNEY
- Country
- ๐ฆ๐บAustralia
- Ownership
- -
- Established
- 1850-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.sydney.edu.au/
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
- Conditions
- Prostatic Neoplasms
- Interventions
- First Posted Date
- 2015-05-18
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- University of Sydney
- Target Recruit Count
- 1125
- Registration Number
- NCT02446405
- Locations
- ๐บ๐ธ
Dana Farber Cancer Institute, Boston, Massachusetts, United States
๐ฆ๐บChris O'Brien Lifehouse, Camperdown, New South Wales, Australia
๐ฆ๐บCoffs Harbour Health Campus, Coffs Harbour, New South Wales, Australia
Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO)
- Conditions
- Diabetic Retinopathy
- Interventions
- Procedure: Targeted laser therapy
- First Posted Date
- 2015-05-04
- Last Posted Date
- 2022-05-31
- Lead Sponsor
- University of Sydney
- Target Recruit Count
- 48
- Registration Number
- NCT02432547
- Locations
- ๐ฆ๐บ
Save Sight Institute, Sydney, New South Wales, Australia
๐ฆ๐บCentre for Eye Research Australia, Melbourne, Victoria, Australia
Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction Monitoring
- Conditions
- Prostate Cancer
- First Posted Date
- 2015-03-24
- Last Posted Date
- 2017-06-22
- Lead Sponsor
- University of Sydney
- Target Recruit Count
- 48
- Registration Number
- NCT02397317
- Locations
- ๐ฆ๐บ
Calvary Mater Newcastle, Newcastle, New South Wales, Australia
๐ฆ๐บLiverpool Cancer Therapy Centre, Sydney, New South Wales, Australia
๐ฆ๐บRoyal North Shore Hospital, Sydney, New South Wales, Australia
CPAP in Preeclampsia
- Conditions
- PreeclampsiaHypertension
- First Posted Date
- 2014-12-01
- Last Posted Date
- 2018-05-03
- Lead Sponsor
- University of Sydney
- Target Recruit Count
- 5
- Registration Number
- NCT02303834
- Locations
- ๐ฆ๐บ
Royal Hospital for Women, Sydney, New South Wales, Australia
๐ฆ๐บRoyal Prince Alfred Hospital, Sydney, New South Wales, Australia
Chemotherapy Followed by Infusion of Partially HLA Matched Unrelated Donor Cells for Patients With AML Who Are Ineligible for Stem Cell Transplantation
- Conditions
- Acute Myeloid Leukaemia
- First Posted Date
- 2014-07-15
- Last Posted Date
- 2015-11-01
- Lead Sponsor
- University of Sydney
- Target Recruit Count
- 12
- Registration Number
- NCT02189824
- Locations
- ๐ฆ๐บ
Westmead Hospital Department of Haematology, Westmead, Sydney, New South Wales, Australia
Near Infrared Photobiomodulation Treatment for Diabetic Macular Oedema
- Conditions
- Diabetic Macular Oedema
- First Posted Date
- 2014-07-03
- Last Posted Date
- 2020-02-07
- Lead Sponsor
- University of Sydney
- Target Recruit Count
- 21
- Registration Number
- NCT02181400
- Locations
- ๐ฆ๐บ
Sydney Eye Hospital, Sydney, New South Wales, Australia
Sub-Study of the PREVIEW Study Australia
- Conditions
- ObesityPre-diabetes
- First Posted Date
- 2014-01-08
- Last Posted Date
- 2021-04-30
- Lead Sponsor
- University of Sydney
- Target Recruit Count
- 292
- Registration Number
- NCT02030249
- Locations
- ๐ฆ๐บ
The University of Sydney, Camperdown, New South Wales, Australia
๐ฆ๐บGarvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales, Australia
๐ฆ๐บPrince of Wales Hospital, Randwick, Sydney, New South Wales, Australia
Using Implementation Intentions to Increase Safe Sex Practices in MSM
- Conditions
- HIVSex
- First Posted Date
- 2013-08-20
- Last Posted Date
- 2013-08-20
- Lead Sponsor
- University of Sydney
- Target Recruit Count
- 180
- Registration Number
- NCT01926418
- Locations
- ๐ฆ๐บ
The Albion Center, Sydney, New South Wales, Australia
99m-Technetium- Glucosamine in Arthritis
- Conditions
- Rheumatoid ArthritisAnkylosing Spondylitis
- First Posted Date
- 2013-02-11
- Last Posted Date
- 2016-10-31
- Lead Sponsor
- University of Sydney
- Registration Number
- NCT01789151
- Locations
- ๐ฆ๐บ
Westmead Hospital, Sydney, New South Wales, Australia
Trial of Switching Between Intravitreal Bevacizumab (Avastinยฎ)& Intravitreal Dexamethasone (Ozurdexโข) for Persistent Diabetic Macular Oedema
- Conditions
- DiabetesDiabetic Macular OedemaDiabetic Macular EdemaDiabetic Retinopathy
- Interventions
- First Posted Date
- 2013-02-08
- Last Posted Date
- 2018-11-13
- Lead Sponsor
- University of Sydney
- Target Recruit Count
- 19
- Registration Number
- NCT01787669
- Locations
- ๐ฆ๐บ
Sydney Eye Hospital, Sydney, New South Wales, Australia
๐ฆ๐บCentre for Eye Research Australia (Royal Victorian Eye & Ear Hospital), Melbourne, Victoria, Australia
๐ฆ๐บLions Eye Institute, Perth, Western Australia, Australia